BETHESDA, Md., Jan. 17, 2023 /PRNewswire/ -- Facial angiofibroma, an aspect of a rare genetic disease called tuberous sclerosis complex (TSC), is the focus of a new online resource, FACE FORWARD, launched by Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland.
Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, today announced that data from a...
Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, will debut HYFTOR™ (sirolimus topical gel) ...